Repeated subcutaneous injections of IL12/23 p40 neutralising antibody, ustekinumab, in patients with relapsing-remitting multiple sclerosis: a phase II, double-blind, placebo-controlled, randomised, dose-ranging study

✍ Scribed by Benjamin M Segal; Cris S Constantinescu; Aparna Raychaudhuri; Lilianne Kim; Rosanne Fidelus-Gort; Lloyd H Kasper

• Book ID: 114408995
• Publisher: The Lancet
• Year: 2008
• Tongue: English
• Weight: 180 KB
• Volume: 7
• Category: Article
• ISSN: 1474-4465
• DOI: 10.1016/s1474-4422(08)70173-x